-
effectivehealthcare-admin.ahrq.gov/products/medicare-medication-use/research
December 01, 2019 - In 2008, the Congressional Budget Office estimated that Medicare Part D expenditures would grow to more
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies-update/research
December 01, 2019 - of limitations in the body of evidence as well as the likely tradeoffs a patient must make between estimated
-
effectivehealthcare-admin.ahrq.gov/products/kidney-disease-medicine/research
December 01, 2019 - In individuals with hyperlipidemia and impaired estimated glomerular filtration rate (eGFR) or creatinine
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/effect-protein-intake-protocol-amendment.pdf
November 29, 2023 - o Incidence of kidney stones or ureteral
stones
o Incidence of CKD (including evaluations
from estimated … =United States; KQ=key
question; CKD=chronic kidney disease; eGFR=estimated glomerular filtration rate … Incidence of
kidney stones or
ureteral stones
o Incidence of
CKD (including
evaluations from
estimated … Incidence of
kidney stones or
ureteral stones
o Incidence of
CKD (including
evaluations from
estimated
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-abnormalities-tests-update_research-protocol.pdf
July 01, 2010 - In the general population, the cumulative risk of being diagnosed with breast cancer by
age 70 is estimated … Elmore et al.10 estimated that a woman’s
cumulative risk of having a false-positive finding on screening
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/masks-appendix-table-b-3-version-2.xlsx
February 01, 2020 - B-3. Obs Studies Masks HCWs
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-3. Observational studies of masks in healthcare settings
Author Publication Year Title Date Retrieved Source Link/URL Study Design Study Da…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/Masks-appendix-table-b-3-surveillance-report.xlsx
February 01, 2020 - B-3. Obs Studies Masks HCWs
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-3. Observational studies of masks in healthcare settings
Author Publication Year Title Date Retrieved Source Link/URL Study Design Study Da…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/masks-surveillance-2-appendix-table-a-3.xlsx
March 23, 2020 - HCWs
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table A-3. Observational studies of masks in healthcare settings
Author Publication Year Title Date Retrieved Source Link/URL Study Design Study Dates Geographic Setting …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/toc.pdf
January 01, 2007 - Medical Care Journal Supplement
Medical Care Journal Supplement 2
Table of Contents
S1 Scott R. Smith. Preface: Research Methods in AHRQ’s Effective Health Care Program.
Med Care. 2007;45(Suppl 2):S1–S2.
S3 David J. Ballard. The Comparative Effectiveness and Safety Emerging Methods
Symposium: A Trib…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medical-test-reviews-meta-analysis.ppt
June 01, 2012 - Within each study, sensitivity and specificity are independent — they are estimated from different patients … Prevalence cannot be estimated from case-control studies (the main design of many medical test studies … Prevalence is often wide-ranging and cannot be estimated from case-control studies which is the main … They can differ when the estimated correlation between sensitivity and specificity is positive and when … Sensitivity and specificity within each study are independent because they are estimated from different
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/medical-test-reviews-meta-analysis.ppt
June 01, 2012 - Within each study, sensitivity and specificity are independent — they are estimated from different patients … Prevalence cannot be estimated from case-control studies (the main design of many medical test studies … Prevalence is often wide-ranging and cannot be estimated from case-control studies which is the main … They can differ when the estimated correlation between sensitivity and specificity is positive and when … Sensitivity and specificity within each study are independent because they are estimated from different
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
December 01, 2015 - In most cases, factors indicative of high risk of bias
were associated with higher values of estimated
-
effectivehealthcare-admin.ahrq.gov/products/n-1-trials/research-2014-2
August 01, 2019 - They estimated 16.75 hours of staff time per trial, which included a physician lead, nursing, data entry … In 1990 U.S. dollars this was estimated at approximately $500/study plus the cost of the medications. … After estimated average per-patient cost offsets of Australian $569 for the gabapentin trial and Australian … $221 for the celecoxib trial, the final estimated 5-year additional costs of n-of-1 trial versus no
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_disposition-comments.pdf
February 13, 2012 - Comparative Effectiveness Research Review Disposition of Comments Report
http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=960
Published Online: February 13, 2012
Comparative Effectiveness Research Review Disposition of Comments Report
Research…
-
effectivehealthcare-admin.ahrq.gov/products/heart-failure-transition-care/policymaker
December 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/menopause_executive.pdf
March 01, 2015 - In the United States, the number of women
entering menopause each year is estimated
to be approximately … Rankings were estimated for
the probability a treatment was most effective, next most
effective, and … Sexual Problems Associated
with Distress and Determinants of Treatment Seeking
(PRESIDE) study25 estimated … placebo 0.26 (-0.001 to 0.52) Insufficient
Pain, interest, global
10 Estrogen route a vs. route b Not estimated
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/masks-appendix-table-b-3-version-1.xlsx
February 01, 2020 - Appendix Table B-3. Observational Studies of Masks in Healthcare Settings
B-3. Obs Studies Masks HCWs
Archived: This living report is not being updated. Findings may be used for research purposes, but should not be considered current.
Appendix Table B-3. Observational studies of masks in healthcare settings
Author …
-
effectivehealthcare-admin.ahrq.gov/products/nonpharma-treatment-pain/research-protocol
December 01, 2019 - It affects millions of adults in the United States, with a conservative annual cost estimated at $560
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
February 01, 2008 - In 2007 an
estimated 218,890 men were diagnosed
with, and 27,050 deaths were attributed to,
prostate … Disease-specific
mortality rates have declined, and an
estimated 1.8 million men living in the
United … Patient treatment decisionmaking
incorporates physician recommendations and estimated
likelihood of … Three reviews estimated the effectiveness and AEs of
laparoscopic and robotic assisted prostatectomy … Hospital readmission rates
were also estimated to be lower in hospitals with greater
volume.
-
effectivehealthcare-admin.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
December 01, 2019 - to be rare. 1 However, without prophylaxis, hospital-acquired deep venous thrombosis (DVT) has been estimated … Major bleeding following THR and TKR is estimated to be 1-3%. 1 Determining the incidence of major bleeding … surgery), in the absence of patient important outcomes, can the risk for such outcomes reliably be estimated